Effects of at1 receptor blockade on blood pressure and the reninangiotensin system in spontaneously hypertensive rats of the stroke prone strain

Clinical and Experimental Hypertension

Volumn 20, Issue 2, 1998, Pages 205-221

  Wagner, Jürgen ^a,d   Drab, Marek ^a   Bohlender, Jürgen ^a   Amann, Kerstin ^b   Wienen, Wolfgang ^c   Ganten, Detlev ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

AT1 receptor antagonists; Hypertension; Renin angiotensin system; Spontaneously hypertensive rats

Indexed keywords

ALBUMIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; CAPTOPRIL; LOSARTAN; MESSENGER RNA; RENIN; TELMISARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; GLOMERULOSCLEROSIS; HEART LEFT VENTRICLE HYPERTROPHY; HEART WEIGHT; HYPERTENSION; KIDNEY INJURY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0031954542     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969809053215     Document Type: Article

References (24)

1. Sigmon DH, Beierwaltes WH. Renal nitric oxide and angiotensin II interaction in renovascular hypertension. Hypertension 1993. 22:237-242
2. Kost CK Jr, Jackson EK. Enhanced renal angiotensin II subtype 1 receptor responses in the spontaneously hypertensive rat. Hypertension 1993. 21:420-421
3. Böhm M, Lee MA, Kreutz R, Kim S, Schinke M, Wagner J, Kaling M, Wienen W, Bader M, Ganten D. Angiotensin II receptor blockade in TGR(mREN2)27: Effects on renin-angiotensin system gene expression and cardiovascular functions. J Hypertens 1995. 13:891-899
4. Brunner HR, Nussberger J, Bumier M, Waeber B. Angiotensin II antagonists. Clin Exp Hypertens 1993. 15:1221-1238
5. Stier CT, Adler LA, Levine S, Chander PN. Stroke prevention by losartan in strokeprone spontaneously hypertensive rats. J Hypertens Suppl. 1993. 11:S37-S42
6. von Lutterotti N, Camargo MJ, Campbell WG, Mueller FB, Timmermanns PB, Sealey JE, Laragh JH. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats. J Hypertens 1992. 10:949-957
7. Bachmann S, Peters J, Engler E, Ganten D, Mullins J: Transgenic rats carrying the mouse renin gene - morphological characterization of a low renin hypertension model. Kidney Int 1992. 41:24-36
8. Pollock DM, Divish BJ, Polakowski JS, Opgenorth TJ. Angiotensin II receptor blockade improves renal function in rats with reduced renal mass. J Pharmacol Exp Ther 1993. 267:657-663
9. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992. 91:766-771
10. Rettig R, Folberth C, Stauss H, Kopf D, Waldherr R, Unger T. Role of the kidney in primary hypertension: a renal transplantation study in rats. Am J Physiol 1990. 258:F606-611
11. Wood JM, Schnell CR, Levens NR. Kidney is an important target for the antihypertensive action of an angiotensin II receptor antagonist in spontaneously hypertensive rats. Hypertension 1993. 21:1056-1061
12. Wu JN, Edwards D, Berecek KH. Changes in renal angiotensin II receptors in spontaneously hypertensive rats by early treatment with the angiotensin - converting enzyme inhibitor captopril. Hypertension 1994. 23:819-822
13. Oddie CJ, Dilley RJ, Kanellakis P, Bobik A. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity. J Hypertens 1993. 11:717-724
14. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension and progressive glomerular damage in Dahl rats. Kidney Int 1984. 26:137-143
15. Auffray C, Rougeon F. Purification of mouse immunoglobulin heavy chain mRNAs from total myeloma tumor RNA. Eur J Biochem 1980. 107:303-314
16. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure; Circ Res 1991. 69:475-482
17. Bohlender J, Ménard J, Wagner J, Luft FC, Ganten D. Human renin-dependent hypertension in transgenic hAOGEN rats. Hypertension 1996, in press
18. Müller DN, Hilgers KF, Bohlender J, Lippoldt A, Wagner J, Fischli W, Ganten D, Mann JFE, Luft FC. Effects of human renin in the vasculature of rats transgenic for human angiotensinogen. Hypertension 1995. 26:272-278
19. Kanagy NL, Fink GD. Losartan prevents salt-induced hypertension in reduced renal mass rats. J Pharmacol Exp Ther 1993. 265:1131-113
20. Wienen W, Hauel N, Van Meel JC, Narr B, Ries U, Enzeroth M; Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277. Br J Pharmacol 1993. 110:245-252
21. Dworkin LD, Benstein JA. Impact of antihypertensive therapy on progressive kidney damage. Am J Hypertens 1989. 2:162S-172S
22. Rockman HA, Wachhorst SP, Mao L, Ross J Jr. ANG II receptor blockade prevents hypertrophy and ANF gene expression with pressure overlaod in mice. Am J Physiol 1994. 266:H2468-2475
23. Mizuno K, Tani M, Hashimoto S, Niimura S, Sanada H, Watanabe H, Ohtsuki M, Fukuchi S. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats. Life Sci 1992. 51:367-374
24. Böhm M, Lippoldt A, Wienen W, Ganten D, Bader M: Reduction of cardiac hypertrophy in TGR(mRNE2)27 by angiotensin II receptor blockade. Mol. Cell Biochem. 1996. 163/164:217-221